PT-141 UK vs Melanotan II — Research Peptide Comparison
PT-141 (Bremelanotide) and Melanotan II are synthetic peptides studied in laboratory environments for their interaction with melanocortin receptor pathways. While both compounds are derived from melanocortin-related peptides and share some structural similarities, they differ in their receptor activity profiles and primary areas of research focus.
This comparison outlines the key differences between PT-141 and Melanotan II in controlled research settings.
This research comparison covers PT-141 UK (Bremelanotide) versus Melanotan II — two melanocortin receptor peptides that have been the subject of significant clinical and preclinical research. Understanding PT-141 UK vs Melanotan II helps researchers select compounds appropriate for their specific study protocols.
Overview of Each Peptide
PT-141 (Bremelanotide)
PT-141 is a synthetic melanocortin analogue studied for its interaction with central melanocortin receptors, particularly in neurochemical signalling pathways.
It is commonly investigated in:
- Neuropeptide signalling research
- Central nervous system studies
- Melanocortin receptor interaction models
Resources & Research Studies:
- Hadley et al. (2000) – Melanocortin receptor peptides and signalling pathways
- Wessells et al. (2000) – Bremelanotide and melanocortin receptor interaction
- Pfaus et al. (2004) – Melanocortin peptides and central nervous system signalling
Melanotan II
Melanotan II is a synthetic analogue of α-MSH (alpha-melanocyte-stimulating hormone), studied for its broader interaction across melanocortin receptor subtypes.
It is commonly investigated in:
- Pigmentation-related research models
- Melanocortin receptor signalling studies
- Neuropeptide and receptor interaction research
Resources & Research Studies:
- Hadley et al. (1998) – Melanocortin peptides and receptor signalling
- Hruby et al. (2001) – α-MSH analogues and melanocortin receptor activity
- Wikberg et al. (2000) – Melanocortin receptors and peptide interactions
Mechanism Comparison
| Feature | PT-141 | Melanotan II |
|---|---|---|
| Peptide Type | Melanocortin analogue | α-MSH analogue |
| Primary Focus | CNS receptor signalling | Broad melanocortin activity |
| Receptor Interaction | Select melanocortin receptors | Multiple MC receptor subtypes |
| Research Focus | Neurochemical pathways | Pigmentation & signalling pathways |
Research Applications
PT-141 is commonly studied in: central nervous system signalling, neuropeptide activity, and melanocortin receptor interaction models.
Melanotan II is commonly studied in: pigmentation signalling pathways, melanocortin receptor activity, and neuropeptide and receptor interaction studies.
Key Differences
- PT-141 is more focused on central melanocortin receptor signalling
- Melanotan II exhibits broader activity across multiple melanocortin receptors
- Melanotan II is structurally related to α-MSH analogues, while PT-141 is a modified melanocortin peptide
Important Notice: This content is provided for informational and research purposes only. All compounds mentioned are intended strictly for laboratory research use. They are not approved for human consumption.
Further Reading
- Complete Guide to Research Peptides UK
- How to Reconstitute Peptides
- Peptide Dosing Calculator
- PT-141 Bremelanotide Research on PubMed
Frequently Asked Questions
What is the difference between PT-141 and Melanotan II?
Both are synthetic peptides studied for their interaction with melanocortin receptor pathways. While both are derived from melanocortin-related peptides and share some structural similarities, they differ in their receptor activity profiles and primary areas of research focus.
What is PT-141 studied for?
PT-141 is a synthetic melanocortin analogue studied for its interaction with central melanocortin receptors, particularly in neuropeptide signalling research, central nervous system studies and melanocortin receptor interaction models.
Are PT-141 and Melanotan II structurally related?
Yes. Both are derived from melanocortin-related peptides and share some structural similarities, though their receptor activity profiles differ.
Are PT-141 and Melanotan II approved medicines?
No. Both are referenced here for laboratory research purposes only and are not approved for human consumption or medical use.